| Managing IP in a difficult economic environment
|
2009 |
Cronin, John |
| Business models, value chains and value propositions
|
2009 |
Arena, Christopher M. |
| Pharmaceutical patents in Italy : hot topics
|
2009 |
Santonocito, Federica |
| Key issues of pharmaceutical trademarks
|
2009 |
Viefhues, Martin |
| IP issues outsourcing R&D
|
2009 |
Milbradt, Claudia |
| Key IP issues for life sciences companies doing business in China
|
2009 |
Lam, Cedric |
| Enforcing plant variety rights in Mexico
|
2009 |
Arceo, Abraham Diaz |
| Standardising IP valuations : whether, what and how
|
2009 |
Sullivan, Patrick H. |
| Life sciences patent strategies in Europe
|
2009 |
Andersson, Inga-Lill |
| Understanding and unifying diverse IP strategy perspectives
|
2009 |
Cronin, John |
| False patent marking : a trap for the unwary patentee
|
2009 |
Vassallo, Edward E. |
| Financing innovation in the developing world
|
2008 |
Ghafele, Roya |
| Issues for pharmaceutical companies doing business in Australia
|
2008 |
Condon, Wayne |
| Maximum value at minimum cost
|
2008 |
Bechtel, J. Scott |
| Superstar brands
|
2008 |
Haigh, David |
| Linking intangible assets to share price
|
2008 |
McDonald, Malcolm |
| Intangible assets and shareholder value
|
2008 |
Torres, Jorge M. |
| The long road to harmonisation
|
2008 |
Adams, Sara-Jayne |
| Increasing transparency in the IP transaction markets
|
2008 |
Henderson, Paul |
| Building a capital market for intangibles
|
2008 |
Jarboe, Kenan Patrick |
Tag hinzufügen